Skip to main content
. 2016 Dec 31;9(4):1496. doi: 10.4022/jafib.1496

Table 2. Baseline Characteristics.

No. of Participants (%)
Characteristics Total Primary Secondary P Value
(n = 216) (n =161) (n=55)
Age, mean (SD), y 76.38 (4.27) 76.40 (4.23) 76.45 (4.50) 0.94
Ischemic
Yes 191 (88.0) 139 (86.3) 51 (92.7) 0.21
No 26 (12.0) 22 (13.7) 4 (7.3)
DM
Yes 119 (54.3) 91 (56.9) 28 (50.9) 0.44
No 100 (45.7) 69 (43.1) 27 (40.1)
Hypertension
Yes 209 (95.0) 156 (96.9) 51 (92.7) 0.18
No 11 (5.0) 5 (3.1) 4 (7.3)
Smoking status
Current smoker 48 (21.9) 36 (22.5) 10 (18.2) 0.78
Former smoker 70 (32.0) 52 (32.5) 18 (32.7)
No smoking 101 (46.1) 72 (45.0) 27 (49.1)
History of Hyperlipidemia
Yes 169 (77.2) 126 (78.7) 42 (76.4) 0.71
No 50 (22.8) 34 (21.3) 13 (23.6)
GFR time, mean (SD), ml/min 59.8 (21.3) 59.7 (21.6) 60.3 (20.4) 0.88
Chronic Kidney Disease
Yes 91 (41.5) 67 (41.9) 24 (43.6) 0.82
No 128 (58.5) 93 (58.1) 31 (56.4)
Atrial Fibrillation
Yes 76 (34.5) 65 (40.4) 11 (20.0) 0.0063
No 144 (65.5) 96 (59.6) 44 (80.0)
Coronary artery disease
Yes 186 (84.5) 138 (85.7) 47 (85.5) 0.96
No 34 (15.5) 23 (14.3) 8 (14.5)
Chronic obstructive pulmonary disease
Yes 62 (28.3) 43 (26.9) 18 (32.7) 0.41
No 157 (71.7) 117 (73.1) 37 (67.3)
Transient ischemic attack/stroke
Yes 18(8.2) 15 (9.4) 3 (5.5) 0.37
No 201 (91.8) 145(90.6) 52 (94.5)